-
Innovation Ranking
NewInnovation Ranking – EO Technics Co Ltd
EO Technics Co Ltd (EOTechnics) is a technology company that manufactures and markets laser processing equipment. It provides equipment for use in manufacturing of semiconductor, liquid crystal displays and printed circuit boards. The company offers products in marking, grooving, dicing, cutting, drilling, notching, annealing, and cleaning facilities. EOTechnics also provides equipment such as semiconductor, display, PCB and macro; lasers including fiber laser, DPSS and DDL. It serves automobile, machine, and other sectors. The company operates through its offices located in...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EOS-984 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EOS-984 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EOS-984 in Solid Tumor Drug Details: EOS-984 is under development for...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – EO-2463 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EO-2463 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EO-2463 in Marginal Zone B-cell Lymphoma Drug Details: EO-2463 is...
-
Product Insights
Val-Eo project
Val-Eo project is an Onshore Wind project located in Quebec, Canada. The project is owned by Algonquin Power & Utilities Corp and others; Val-Eo Cooperative de solidarite and is developed by Eoliennes Belle-Riviere Inc. The project is currently partially active. Empower your strategies with our Val-Eo project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EO-4010 in Metastatic Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EO-4010 in Metastatic Colorectal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. EO-4010 in Metastatic Colorectal Cancer Drug Details: EO-4010 is under development...
-
Product Insights
EOS Floating Wind Farm Project
EOS Floating Wind Farm Project is an offshore wind project located in Mediterranean Sea, France. The project is expected to come online in 2030. Empower your strategies with our EOS Floating Wind Farm Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...
-
Product Insights
EOS Floating Wind Farm Project_Two
EOS Floating Wind Farm Project_Two is an offshore wind project located in Mediterranean Sea, France. The project is expected to come online in 2030. Empower your strategies with our EOS Floating Wind Farm Project_Two report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...
-
Sector Analysis
NewAlbania Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Albania Defense Market Report Overview The Albania defense budget is valued at $346.5 million and is expected to grow at a CAGR of more than 7% during 2025-2029. The Russian invasion of Ukraine has spurred the country’s defense budget like many other European nations. Albania Defense Market Outlook, 2024-2029 ($ Million) Buy the Full Report for More Insights into the Albania Defense Market Forecast Download a Free Report Sample The Albania defense market research report provides the market size forecast...
-
Sector Analysis
NewOman Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2029
Oman Defense Market Report Overview The Oman defense budget is $8 billion in 2024. The country’s defense budget will grow at a CAGR of more than 2% during 2025-2029. This can be attributed to the rising arms race in the region to intercept the growing turbulence in neighboring countries such as Syria and Yemen. In addition, the increase in oil prices will facilitate increases in Oman's defense budget. Oman Defense Market Outlook, 2024-2029 ($ Billion) Buy the Full Report for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Belrestotug in Refractory Multiple Myeloma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Belrestotug in Refractory Multiple Myeloma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Belrestotug in Refractory Multiple Myeloma Drug Details: EOS-448 is under development...